【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Recurrent Malignant Glioma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Recurrent Malignant Glioma to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Recurrent Malignant Glioma to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Recurrent Malignant Glioma 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Recurrent Malignant Glioma Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Insys Therapeutics, Inc. 33
Clinical Trial Overview of Insys Therapeutics, Inc. 33
Merck & Co., Inc. 34
Clinical Trial Overview of Merck & Co., Inc. 34
Eisai Co., Ltd. 35
Clinical Trial Overview of Eisai Co., Ltd. 35
TransMolecular, Inc. 36
Clinical Trial Overview of TransMolecular, Inc. 36
Eli Lilly and Company 37
Clinical Trial Overview of Eli Lilly and Company 37
to-BBB technologies BV 38
Clinical Trial Overview of to-BBB technologies BV 38
Tactical Therapeutics, Inc 39
Clinical Trial Overview of Tactical Therapeutics, Inc 39
Shandong Lanjin Pharmaceuticals Co. Ltd 40
Clinical Trial Overview of Shandong Lanjin Pharmaceuticals Co. Ltd 40
Direct Therapeutics, Inc. 41
Clinical Trial Overview of Direct Therapeutics, Inc. 41
Amgen Inc. 42
Clinical Trial Overview of Amgen Inc. 42
Clinical Trial Overview of Top Institutes / Government 43
National Cancer Institute 43
Clinical Trial Overview of National Cancer Institute 43
Duke University 45
Clinical Trial Overview of Duke University 45
Memorial Sloan Kettering Cancer Center 47
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 47
North American Brain Tumor Consortium 48
Clinical Trial Overview of North American Brain Tumor Consortium 48
The University of Texas M. D. Anderson Cancer Center 49
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 49
Northwestern University 50
Clinical Trial Overview of Northwestern University 50
UCLA’s Jonsson Comprehensive Cancer Center 51
Clinical Trial Overview of UCLA’s Jonsson Comprehensive Cancer Center 51
Sidney Kimmel Comprehensive Cancer Center 52
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 52
University of Colorado 53
Clinical Trial Overview of University of Colorado 53
Wake Forest University 54
Clinical Trial Overview of Wake Forest University 54
Five Key Clinical Profiles 55
Appendix 178
Abbreviations 178
Definitions 178
Research Methodology 179
Secondary Research 179
About GlobalData 180
Contact Us 180
Disclaimer 180
Source 181
【レポート販売概要】
■ タイトル：再発悪性神経膠腫：グローバル臨床試験レビュー（2014年上半期）■ 英文：Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2014
■ 発行日：2014年4月15日
■ 調査会社：GlobalData
■ 商品コード：GDHC2080CTIDB
■ 調査対象地域：グローバル
- 再発性多発性硬化症(RMS)治療のグローバル臨床試験動向（2014年下半期）Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2014" provides data on the Relapsing Multiple Sclerosis (RMS) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Relapsing Multiple Sclerosis (RMS). …
- 世界のエコーウイルス検査市場The report presents a detailed analysis of the Echovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Echovirus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Comm …
- 防音材の世界市場分析：製品別（グラスウール、岩綿、発泡プラスチック）、用途別（建築＆建設（商業、住宅）、産業、輸送（自動車、船舶、航空宇宙））、セグメント予測 2014-2025The global acoustic insulation market is expected to reach USD 16.55 billion in 2025, according to a new report by Grand View Research, Inc. Increasing standard of living, awareness regarding the effect of noise pollution on human health and stringent regulations have been driving the global acoustic insulation market so far. Market growth will probably be driven by consumer needs and initiatives, …
- エッグトレーの世界市場2017-2021About Egg TrayEgg trays are mainly used for transportation and storage. They are built in such a way that they can be stacked, which facilitates bulk transportation. Such trays are mainly used by poultry farmers or wholesalers to transport eggs in bulk for retailers. The size of egg trays carrying eggs may vary depending on factors such as distance and the type of product offering. Technavio’s ana …
- 医療用圧力モニタリング製品の世界市場：血圧モニタリング、頭蓋内圧モニタリング、眼圧モニタリング、肺動脈圧モニタリングPressure monitoring plays an important role in detecting the health problems of a patient. The major fluctuations of pressure in the vital areas of the body may cause various chronic and acute diseases such as diabetes, cardiac arrest, and glaucoma. Increase in the prevalence of the above mentioned diseases and growing aging population have increased the need for pressure monitoring and control in …
- 勃起不全(ED)薬の世界市場2019-2023About this market The high prevalence of conditions resulting in ED is one of the key factors expected to trigger the market’s growth in the forthcoming years. Various health conditions including diabetes, hypertension, obesity, depression, stress, and excessive alcohol consumption are resulting in the rising incidences of ED among elderly as well as young people. As these conditions directly alte …
- 嚢胞性線維症（CF）治療薬の世界市場：薬物クラス別（膵酵素サプリメント、粘液溶解薬、気管支拡張薬、CFTRモジュレーター）、投与経路別（経口、吸入）The global cystic fibrosis therapeutics market was valued at $4,615.4 million in 2018 and is expected to reach $9,277.3 million by 2026, registering a CAGR of 9.2% from 2019 to 2026. Cystic fibrosis is a progressive, hereditary disease that led to insistent lung infections and limits the patient’s ability to breathe over time. Diagnosis of cystic fibrosis is a multistep process, and includes a new …
- 萎縮性胃炎(Atrophic Gastritis)：世界の治験レビュー（2015年上半期版）Atrophic Gastritis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Atrophic Gastritis Global Clinical Trials Review, H1, 2015" provides data on the Atrophic Gastritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Atrophic Gastritis. It includes an overview of the trial numbers and their recruitme …
- 医療機器製造アウトソーシングの世界市場2016-2020About the Medical Device Manufacturing Outsourcing Market Medical technology is an integral part of the healthcare sector, which includes a wide range of healthcare products, devices, and techniques that are used to diagnose and treat diseases or medical conditions. These technologies are used to improve the quality of healthcare delivered through early diagnosis and effective therapy. Recent adva …
- 世界のファブレット（Phablet）市場動向（2012-2016）TechNavio's analysts forecast the Global Phablet market to grow at a CAGR of 26.9 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing adoption of phablets in the emerging markets. The Global Phablet market has also been witnessing an increased R&D spending. However, high production costs could pose a challenge to the growth of this market. …
- 社員採用ソフトウェアのグローバル市場（2014-2018）About Recruitment Software Recruitment software provides a complete set of tools to help organizations recruit employees more efficiently. Recruitment software is either deployed by an in-house recruiting department or by a recruiting agency. The software includes various features such as job posting, applicant tracking, pre-screening questions and response tracking, scheduling and tracking of int …
- 予防医療技術とサービスの世界市場の規模および予測：技術別（早期発見とスクリーニング、ワクチン、慢性疾患管理、先進技術によるエラー削減）、セグメント予測、2013-2024The global preventive healthcare technologies and services market is expected to reach USD 432.4 billion by 2024, according to a new report by Grand View Research, Inc. Key factors driving the market expansion include the growing awareness about preventive measures, which enhance the quality of life, lifespan, and minimize the possible healthcare spending. The growth of this market is attributed t …
- 世界の主蒸気隔離弁市場2015The Global Main Steam Isolation Valves Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Main Steam Isolation Valves industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Main Steam Isolation Valves market analysis is provided for the international mark …
- 貨物輸送の世界市場：液体貨物、バラ積み乾貨物、一般貨物、コンテナー貨物In the past decade it has been seen that world economic activity, trade liberalization and current growth in Asian economies is the main driving cause in global marine industry. In the upcoming years, the industry is projected to get benefit from improving trade levels with greater demand from the logistics and shipping sectors. Trade between Asian countries and the rest of the world is expected t …
- 薬物および遺伝子送達デバイスの世界市場規模及び予測：遺伝子送達別（経口、吸入、経皮、注射、眼、鼻、局所）、遺伝子送達ベクター別（ウイルス性、非ウイルス性）、遺伝子送達別（その場、体外）、セグメント予測、2014-2025The global drug and gene delivery systems market is expected to reach USD 786.9 Billion by 2025, according to a new report by Grand View Research, Inc. Rising investment by the market players to develop innovative drug delivery systems to cater to the demand by the patients as well as to increase the bioavailability at minimum quantity of active pharmaceutical ingredient is driving the market grow …
